"The
final rule is the latest action taken by the FDA to promote consistency in the regulation of devices. This action is intended to harmonize the FDA’s CGMP regulatory framework used by other regulatory authorities.
"The rule is effective February 2, 2026, two years after publication. Until then, manufacturers are required to comply with the QS regulation."